Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Myeloblastic, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05720988
What this trial is testing

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT06463639
What this trial is testing

FLT3 Clonal Evolution in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,213
Not applicableUnknownNCT05983172
What this trial is testing

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,500
Early research (Phase 1)Study completedNCT00867230
What this trial is testing

FTS Study in Patients With Advanced Hematologic Malignancies

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 18
Large-scale testing (Phase 3)UnknownNCT00111345
What this trial is testing

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Who this might be right for
Myeloid Leukemia
University Hospital Muenster 550
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT02472145
What this trial is testing

An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Janssen Research & Development, LLC 326
Early research (Phase 1)Study completedNCT00006239
What this trial is testing

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT04742101
What this trial is testing

Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institut de Recherches Internationales Servier 57
Early research (Phase 1)UnknownNCT05731219
What this trial is testing

UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Early research (Phase 1)Study completedNCT01629082
What this trial is testing

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myeldysplastic Syndrome (MDS)Chronic Myelomonocytic LeukemiaBone Marrow Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Early research (Phase 1)Study completedNCT05987696
What this trial is testing

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

Who this might be right for
AML, AdultMinimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 2
Testing effectiveness (Phase 2)Looking for participantsNCT06672146
What this trial is testing

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Not applicableLooking for participantsNCT06945042
What this trial is testing

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Wake Forest University Health Sciences 120
Not applicableNot Yet RecruitingNCT06090786
What this trial is testing

Kinetics and Impact on Survival of MRD in AML Patients Receiving Azacitidine and Venetoclax

Who this might be right for
AML, AdultMinimal Residual Disease
Gruppo Italiano Malattie EMatologiche dell'Adulto 225
Not applicableStudy completedNCT02584296
What this trial is testing

Physical Activity as Self-Management Approach to Improve Health Outcomes in AML

Who this might be right for
LeukemiaMyeloidMonocytic
Virginia Commonwealth University 23
Large-scale testing (Phase 3)Study completedNCT02997202
What this trial is testing

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 356
Testing effectiveness (Phase 2)Ended earlyNCT04240002
What this trial is testing

Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
Astellas Pharma Global Development, Inc. 9
Next Page